Christine Stürken
Priv.-Doz. Dr. rer. nat.
Christine Stürken
  • Wissenschaftliche Mitarbeiterin
Arbeitsbereich

Standort

N62 , EG, Raumnummer 2
Sprachen
Deutsch (Muttersprache)
Englisch

Tätigkeitsschwerpunkte

Publikationen

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2006
  • 2005
Vor

Immunohistochemical Analysis of Transcription Factors and Markers of Epithelial-Mesenchymal Transition (EMT) in Human Tumors
Ghulam J, Stuerken C, Wicklein D, Pries R, Wollenberg B, Schumacher U
ANTICANCER RES. 2019;39(10):5437-5448.

Transcriptome Guided Drug Combination Suppresses Proliferation of Breast Cancer Cells
Shkurnikov M, Poloznikov A, Nikulin S, Schumacher U, Wicklein D, Stürken C, Galatenko V, Alekseev B
BULL EXP BIOL MED. 2019;166(5):656-660.

Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium
Boecker W, van Horn L, Stenman G, Stürken C, Schumacher U, Loening T, Liesenfeld L, Korsching E, Gläser D, Tiemann K, Buchwalow I
LAB INVEST. 2018;98(8):1065-1075.

In Vitro Model for Studying of the Role of IGFBP6 Gene in Breast Cancer Metastasizing
Nikulin S, Raigorodskaya M, Poloznikov A, Zakharova G, Schumacher U, Wicklein D, Stürken C, Riecken K, Fomicheva K, Alekseev B, Shkurnikov M
BULL EXP BIOL MED. 2018;164(5):688-692.

Role of IGFBP6 Protein in the Regulation of Epithelial-Mesenchymal Transition Genes
Nikulin S, Raigorodskaya M, Poloznikov A, Zakharova G, Schumacher U, Wicklein D, Stürken C, Riecken K, Fomicheva K, Alekseev B, Shkurnikov M
BULL EXP BIOL MED. 2018;164(5):650-654.

Tumormetastasierung: Molekularbiologische Forschung Wenn Krebs in Zukunft erfolgreich behandelt werden soll, dann müssen wir die Prozesse der Metastasierung genau verstehen, um daraus neue therapeutische Ansätze zu entwickeln
Schumacher U, Stürken C, Schmalfeldt B
Hamb Ärztebl. 2018;72(11):12-15.

Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast
Boecker W, Stenman G, Stürken C, Schumacher U, Loening T, Stahnke L, Löhnert C, Siering R, Kuper A, Samoilova V, Tiemann M, Korsching E, Buchwalow I
VIRCHOWS ARCH. 2017;470(5):493-504.

Selectin-independent adhesion during ovarian cancer metastasis
Khaustova N, Maltseva D, Oliveira-Ferrer L, Stürken C, Milde-Langosch K, Makarova J, Rodin S, Schumacher U, Tonevitsky A
BIOCHIMIE. 2017;142:197-206.

Naturapotheke Mistel: Ein immergrüner Halbparasit in der Onkologie
Pfüller U, Stürken C
Biol. Unserer Zeit. 2017;47(4):240 - 244.

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases
Witzel I, Marx A, Müller V, Wikman H, Matschke J, Schumacher U, Stürken C, Prehm P, Laakmann E, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L
BREAST CANCER RES TR. 2017;162(3):427-438.

Das Rätsel der Metastasierung. Warum gibt es so wenig Erfolge in der Krebstherapie?
Schumacher U, Stürken, geb. Schröder C
Biol. Unserer Zeit. 2016;46(6):350-356.

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients
Milde-Langosch K, Schütze D, Oliveira-Ferrer L, Wikman-Kocher H, Müller V, Lebok P, Pantel K, Schröder C, Witzel I, Schumacher U
BREAST CANCER RES TR. 2015;151(3):515-28.

Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties
Oliveira-Ferrer L, Kürschner M, Labitzky V, Wicklein D, Müller V, Lüers G, Schumacher U, Milde-Langosch K, Schröder C
J CANCER RES CLIN. 2015;141(10):1715-26.

c-FOS suppresses ovarian cancer progression by changing adhesion
Oliveira Ferrer L, Rößler K, Haustein V, Schröder C, Wicklein D, Maltseva D, Khaustova N, Samatov T, Tonevitsky A, Mahner S, Jänicke F, Schumacher U, Milde-Langosch K
BRIT J CANCER. 2014;110(3):753-63.

Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells.
Dippel V, Milde-Langosch K, Wicklein D, Schumacher U, Altevogt P, Oliveira-Ferrer L, Jänicke F, Schröder C
J CANCER RES CLIN. 2013;139(1):107-121.

Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients
Schröder C, Milde-Langosch K, Gebauer F, Schmid K, Müller V, Wirtz R, Meyer-Schwesinger C, Schluter H, Sauter G, Schumacher U
J CANCER RES CLIN. 2013;139:1745-1755.

Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue
Stubbendorff M, Deuse T, Hua X, Phan T, Bieback K, Atkinson K, Eiermann T, Velden J, Schröder C, Reichenspurner H, Robbins R, Volk H, Schrepfer S
STEM CELLS DEV. 2013;22(19):2619-29.

Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel I, Schröder C, Müller V, Zander H, Tachezy M, Henningsen M, Jänicke F, Milde-Langosch K
ONCOLOGY. 2012;82(6):305-312.

Myeloperoxidase attracts neutrophils by physical forces.
Klinke A, Nussbaum C, Kubala L, Friedrichs K, Rudolph T, Rudolph V, Paust H, Schröder C, Benten D, Lau D, Szöcs K, Furtmüller P, Heeringa P, Sydow K, Duchstein H, Ehmke H, Schumacher U, Meinertz T, Sperandio M, Baldus S
BLOOD. 2011;117(4):1350-1358.

Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation.
Richter U, Schröder C, Wicklein D, Lange T, Geleff S, Dippel V, Schumacher U, Klutmann S
Histochem Cell Biol. 2011;135(5):499-512.

Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
Schröder C, Witzel I, Müller V, Krenkel S, Wirtz R, Jänicke F, Schumacher U, Milde-Langosch K
J CANCER RES CLIN. 2011;137(8):1193-1201.

The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
Schröder C, Schumacher U, Müller V, Wirtz R, Streichert T, Richter U, Wicklein D, Milde-Langosch K
EUR J CANCER. 2010;46(9):1650-1660.

Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
Knippen S, Löning T, Müller V, Schröder C, Jänicke F, Milde-Langosch K
ANTICANCER RES. 2009;29(1):183-189.

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Henningsen M, Müller V, Wirtz R, Schröder C, Krenkel S, Witzel I, Lisboa B, Jänicke F, Milde-Langosch K
BREAST CANCER RES TR. 2008;112(3):419-427.

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Milde-Langosch K, Janke S, Wagner I, Schröder C, Streichert T, Bamberger A, Jänicke F, Löning T
BREAST CANCER RES TR. 2008;107(3):337-347.

PslD is a secreted protein required for biofilm formation by Pseudomonas aeruginosa.
Campisano A, Schröder C, Schemionek M, Overhage J, Rehm B
APPL ENVIRON MICROB. 2006;72(4):3066-3068.

Evidence for two recA genes mediating DNA repair in Bacillus megaterium.
Nahrstedt H, Schröder C, Meinhardt F
MICROBIOL-SGM. 2005;151(3):775-787.

Letzte Aktualisierung aus dem FIS: 09.12.2019 - 00:37 Uhr